Strain Information | |
---|---|
Image | |
BRC No. | RBRC11727 |
Type | Targeted Mutation |
Species | Mus musculus |
Strain name | B6J.B6N-Islr<tm1b(EUCOMM)Wtsi>/Ea |
Former Common name | Meflin-KO |
H-2 Haplotype | |
ES Cell line | JM8A3.N1 [C57BL/6N-A<tm1Brd>] |
Background strain | |
Appearance | |
Strain development | |
Strain description | |
Colony maintenance | |
References | Cancer Res., 79(20):5367-5381 (2019). 31439548 Genomics, 44: 273-279 (1997). 9325048 Sci. Rep., 6:22288 (2016). 26924503 Circ. Res., 25(4):414-430 (2019). 31221024 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |
---|---|
Gene info | Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter Islrimmunoglobulin superfamily containing leucine-rich repeat9Islr<tm1b(EUCOMM)Wtsi>targeted mutation 1b, Wellcome Trust Sanger InstituteMeflin Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter En2En2 SA (mouse En2 intron 2/exon 3 splice acceptor sequence)9En2 Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter Frtyeast FRT (flippase recombination target) site9Frt Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter Iresinternal ribosomal entry site (EMCV)9 Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter lacZbeta-galactosidase (E. coli)9 Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter loxPphage P1 loxP9loxP |
Ordering Information | |
---|---|
Donor DNA | Saccharomyces cerevisiae yeast FRT (flippase recombination target) site, Mouse En2 intron 2/exon 3 splice acceptor sequence (En2 SA), EMCV internal ribosomal entry site (IRES), E. coli lacZ, Phage P1 loxP site, mouse Islr genomic DNA |
Research application | Cre/loxP system FLP/frt system Fluorescent Proteins/lacZ System |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Sci. Rep., 6:22288 (2016). Cancer Res., 79(20):5367-5381 (2019). Circ. Res., 125(4):414-430 (2019).In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The availability of the BIOLOGICAL RESOURCE is restricted to a RECIPIENT of a not-for profit organization for a not-for-profit research. The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. The RECIPIENT shall acknowledge the EUCOMM as the Provider of the ES cells to generate KO mice. |
Depositor | Atsushi Enomoto (Nagoya University) |
Strain Status | Frozen sperm |
Strain Availability | Recovered litters from cryopreserved sperm (2 to 4 months) Cryopreserved sperm (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |